About VBI Vaccines
VBI Vaccines is a company based in Cambridge (United States) founded in 2001. It operates as a Direct-to-Consumer (D2C), and B2B2C. VBI Vaccines has raised $65.07 million across 23 funding rounds from investors including Blackstone, National Research Council Canada and RTW Investments. VBI Vaccines has completed 2 acquisitions, including Epixis and SciVac Therapeutics. VBI Vaccines offers products and services including PreHevbrio and VBI-2601. VBI Vaccines operates in a competitive market with competitors including Moderna, Adaptive Biotechnologies, Chimerix, HOOKIPA Pharma and Novavax, among others.
- Headquarter Cambridge, United States
- Stage Public
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Vbi Vaccines Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$65.07 M (USD)
in 23 rounds
-
Latest Funding Round
-
Investors
Blackstone
& 7 more
-
Employee Count
Employee Count
-
Investments & Acquisitions
Epixis
& 1 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of VBI Vaccines
VBI Vaccines offers a comprehensive portfolio of products and services, including PreHevbrio and VBI-2601. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
A hepatitis B vaccine is developed for prevention.
An HBV immunotherapeutic is designed for treatment purposes.
Unlock access to complete
Unlock access to complete
Funding Insights of VBI Vaccines
VBI Vaccines has successfully raised a total of $65.07M across 23 strategic funding rounds. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 23
- Last Round Last Round
-
First Round
First Round
(04 Jan 2007)
- Investors Count 8
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug, 2020 | Amount | Grant - VBI Vaccines | Valuation |
investors |
|
| May, 2020 | Amount | Post-IPO - VBI Vaccines | Valuation |
investors |
|
| Apr, 2020 | Amount | Post-IPO - VBI Vaccines | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in VBI Vaccines
VBI Vaccines has secured backing from 8 investors, including institutional and venture fund investors. Prominent investors backing the company include Blackstone, National Research Council Canada and RTW Investments. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Health-tech companies are targeted for venture capital investments.
|
Founded Year | Domain | Location | |
|
Venture capital firm focused on life science companies
|
Founded Year | Domain | Location | |
|
Life Sciences focused VC firm investing in the US
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by VBI Vaccines
VBI Vaccines has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Epixis and SciVac Therapeutics. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Hepatitis B vaccine development was focused on by SciVac Therapeutics.
|
2005 | ||||
|
French biotech developing e-VLP (virus like particles) immunotherapies for Hep-C. Acquired by VBI Vaccines in 2011
|
2003 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - VBI Vaccines
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Vbi Vaccines Comparisons
Competitors of VBI Vaccines
VBI Vaccines operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Moderna, Adaptive Biotechnologies, Chimerix, HOOKIPA Pharma and Novavax, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
mRNA-based therapeutics for diseases including cancer and infections are developed.
|
|
| domain | founded_year | HQ Location |
Clinical diagnostics and drug discovery for immune diseases are provided.
|
|
| domain | founded_year | HQ Location |
Antiviral oral therapeutics are developed for infectious diseases and cancers.
|
|
| domain | founded_year | HQ Location |
Developer of immunotherapies for the treatment of infectious diseases and cancer
|
|
| domain | founded_year | HQ Location |
Novel vaccines are developed using nanoparticle and matrix adjuvant technology.
|
|
| domain | founded_year | HQ Location |
Developer of novel protein-based therapeutics using machine learning and biological engineering
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Vbi Vaccines
Frequently Asked Questions about VBI Vaccines
When was VBI Vaccines founded?
VBI Vaccines was founded in 2001 and raised its 1st funding round 6 years after it was founded.
Where is VBI Vaccines located?
VBI Vaccines is headquartered in Cambridge, United States. It is registered at Cambridge, Massachusetts, United States.
Is VBI Vaccines a funded company?
VBI Vaccines is a funded company, having raised a total of $65.07M across 23 funding rounds to date. The company's 1st funding round was a Post-IPO of $1.06M, raised on Jan 04, 2007.
What does VBI Vaccines do?
VBI Vaccines is focused on the development of vaccine and immunotherapeutic candidates aimed at addressing significant unmet needs in infectious diseases and oncology. The company operates in the healthcare sector, targeting conditions such as hepatitis B and various cancers with innovative solutions. Their pipeline includes both prophylactic vaccines to prevent diseases and therapeutic immunotherapeutics to treat existing conditions by harnessing the immune system. Operations are supported by facilities in the United States, Canada, and Israel, covering research, development, and manufacturing activities.
Who are the top competitors of VBI Vaccines?
VBI Vaccines's top competitors include Moderna, Adaptive Biotechnologies and Generate Biomedicines.
What products or services does VBI Vaccines offer?
VBI Vaccines offers PreHevbrio and VBI-2601.
How many acquisitions has VBI Vaccines made?
VBI Vaccines has made 2 acquisitions, including Epixis, and SciVac Therapeutics.
Who are VBI Vaccines's investors?
VBI Vaccines has 8 investors. Key investors include Blackstone, National Research Council Canada, RTW Investments, Opko Health, and Arch Venture Partners.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.